Page 51 – Re-audit of gastrointestinal tract specimens with respect to compliance with RCPath guidelines
Dr Manisha Ram and Dr Moina Kadri
References
1. Buas MF, Vaughan TL. Epidemiology and risk factors for gastroesophageal junction tumors: understanding the rising incidence of this disease. Semin Radiat Oncol 2013;23:3–9.
2. Byrne JP, Parry JM, Woodman CJB et al. The epidemiology of adenocarcinoma of the esophagus and gastric cardia in the North West of England. In: Giuli R, Galmiche J-P, Jamieson GG, Scarpignato C (eds). The esophagogastric junction. Paris, France: John Libbey Eurotext, 1998.
3. The Royal College of Pathologists. Dataset for the histopathological reporting of gastric carcinoma (2nd edition). London, UK: The Royal College of Pathologists, 2007.
4. The Royal College of Pathologists. Dataset for the histopathological reporting of oesophageal carcinoma (2nd edition). London, UK: The Royal College of Pathologists, 2007.
5. Allum WH, Blazeby JM, Griffin SM, Cunningham D, Jankowski JA, Wong R; Association of Upper Gastrointestinal Surgeons of Great Britain and Ireland, the British Society of Gastroenterology and the British Association of Surgical Oncology. Guidelines for the Management of Oesophageal and Gastric Cancer. Gut 2011;60:1449–1472.
